Abstract Although the common marmoset (Callithrix jacchus) has been maintained in captivity in biomedical research settings for decades, interest and use of the species as an animal model for a diverse array of purposes has increased in the 21st century. Unfortunately, the development of validated animal care standards such as nutrition, husbandry, and clinical care has not expanded with the same rapidity as the use of the species in research. The goal of this themed issue of the ILAR Journal is to review current literature relevant to topics that impact marmoset health, welfare, and use in research. As the population of captive marmosets increases worldwide, the editors urge scientists, veterinary clinicians, and colony managers to continue conducting and publishing robust studies to develop evidence-based standards related to marmoset care and use. The editors also encourage IACUCs and other institutional review bodies to seek training on topics relevant to marmoset welfare and develop related policies prior to acquiring animals as a novel species.

Animal studies in pharmaceutical drug discovery are common in preclinical research for compound evaluation before progression into human clinical trials. However, high rates of drug development attrition have prompted concerns regarding animal models and their predictive translatability to the clinic. To improve the characterization and evaluation of animal models for their translational relevance, the authors developed a tool to transparently reflect key features of a model that may be considered in both the application of the model but also the likelihood of successful translation of the outcomes to human patients. In this publication, we describe the rationale for the development of the Animal Model Quality Assessment tool, the questions used for the animal model assessment, and a high-level scoring system for the purpose of defining predictive translatability. Finally, we provide an example of a completed Animal Model Quality Assessment for the adoptive T-cell transfer model of colitis as a mouse model to mimic inflammatory bowel disease in humans.

AbstractAnimal research is currently an irreplaceable contributor to our efforts to protect and improve public health. Its relevance, importance, and contributions are represented in historical precedent, regulatory expectations, evidence of our rapidly developing understanding of human health and disease, as well as success in the development of novel therapeutics that are improving quality of life and extending human and animal life expectancy. The rapid and evolving success in responding to the current COVID pandemic significantly supported by animal studies is a clear example of the importance of animal research. But there is growing interest in reducing our dependence on animals and challenges to the effective translation of current animal studies to human applications. There are several potential contributors to gaps in the translatability of animal research to humans, including our approaches to choosing or rationalizing the relevance of a particular animal model, our understanding of their biological variability and how that applies to outcomes, the data we collect from animal studies, and even how we manage the animals. These important contributors to the success of animal research are explored in this issue of the ILAR Journal.

The Animal Care Panel is a nonprofit educational association of individuals and institutions concerned with the production, care, and study of laboratory animals. The entire United States and several foreign countries are represented in its membership. The Panel provides for the exchange of scientific information on all phases of laboratory animal care. It compiles and distributes information on films dealing with the handling of laboratory animals, and has initiated an animal technicians' training program. It publishes a bimonthly journal, "Laboratory Animal Care;" sponsors annual awards designed to encourage and reward outstanding accomplishment in the improvement of the care and quality of laboratory animals; and maintains close liaison with the Institute of Laboratory Resources (National Research Council), the American Veterinary Medical Association (through the American College of Laboratory Animal Medicine), the Laboratory Animal Breeders Association, and the National Society for Medical Research. Through its Animal Facilities Standards Committee, the Panel gathers and examines information that will aid in the establishment of high standards for the care of animals. The Guide for Laboratory Animal Facilities and Care was adopted by the Institute of Laboratory Animal Resources, National Academy of Sciences-National Research Council, on January 28, 1963.

The organization and function of the institutional animal care and use committee (IACUC) is the key component of government regulation and oversight of necessary scientific research using live animals and of AAALAC - International accreditation of animal care and use programs in the United States. The regulations, roles, and responsibilities of IACUCs have evolved since their inception 35years ago from a limited focus on animal welfare and specific animal procedures to embracing scientific quality, data reproducibility and translation, and animal welfare as inextricably interdependent and critical components of generation of new scientific knowledge and medical treatments. A current challenge for IACUCs is in evaluating whether benefits to be derived (eg, new knowledge or treatments) justify any unavoidable pain, stress, or injury associated with proposed research protocols, because the former are long-term and at best speculative outcomes, whereas the latter are immediate and tangible for the study animals. Scientific consensus is that research most likely to generate significant new knowledge and medical treatments is that conducted to high scientific, technical, and quality standards and reported with full transparency to facilitate reproducibility. As an alternative to current benefits evaluations included in risk benefit and harm benefit constructs, the authors propose that IACUCs assess the proposed research for scientific quality and alignment of study elements with the study purpose (e.g., Fit for Purpose [FfP]), including justifications for study design components, selection of primary endpoints and technologies, rationale for data and statistical analyses, and research communication plans. Fit for Purpose endpoints are objective, immediate, and impactful as are the potential risks for study animals, and at the same time they are the best predictors for achievement of longer-term benefits. We propose that IACUCs and any revision of The ILAR Guide consider FfP concepts in place of traditional benefits assessment to accelerate the generation of new knowledge and treatments benefiting medical and veterinary patients and the environment through better science and animal welfare rather than to continue to rely on speculative future outcomes.

Animals are valuable resources in biomedical research in investigations of biological processes, disease pathogenesis, therapeutic interventions, safety, toxicity, and carcinogenicity. Interpretation of data from animals requires knowledge not only of the processes or diseases (pathophysiology) under study but also recognition of spontaneous conditions and background lesions (pathology) that can influence or confound the study results. Species, strain/stock, sex, age, anatomy, physiology, spontaneous diseases (noninfectious and infectious), and neoplasia impact experimental results and interpretation as well as animal welfare. This review and the references selected aim to provide a pathology resource for researchers, pathologists, and veterinary personnel who strive to achieve research rigor and validity and must understand the spectrum of "normal" and expected conditions to accurately identify research-relevant experimental phenotypes as well as unusual illness, pathology, or other conditions that can compromise studies involving laboratory mice, rats, gerbils, guinea pigs, hamsters, naked mole rats, and rabbits.

Abstract The principal investigator is an expert on the topic under investigation. The veterinarian is an expert in the health and wellness of an animal. But what, exactly, can ethicists add to discussions about animal research? This special issue of the ILAR Journal considers how contemporary ethics scholarship can be relevant to animal research. The articles were selected to highlight how clear thinking about values and the implications of those values can inform which research is conducted and how it is conducted.